ArticleBMJ public health2026
Area deprivation and hepatitis C infection in Korea: a multilevel case-control study using the National Health Insurance Database.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hepatitis C virus (HCV), a major cause of chronic liver disease, shows decreasing prevalence in Korea, yet regional disparities persist. This study aimed to examine the impact and temporal changes in individual characteristics and regional health inequalities on HCV infection to provide a framework for HCV elimination and management. Methods: This nationwide population-based multilevel case-control study analysed 252 993 patients with HCV and 4 000 000 controls using National Health Insurance Service (NHIS) and population census data from 2005, 2010, 2015 and 2020. The Area Deprivation Index (ADI) was calculated for each area (region/town) using population census data. Sex-standardised and age-standardised HCV prevalences were estimated for each area using NHIS data. The association between area-level HCV and ADI was examined using correlation and linear regression analyses. Individual-level and area-level HCV infection risks were estimated using logistic regression and multilevel logistic regression models incorporating sex, age, HCV prevalence and ADI. Results: The HCV prevalence (per 100 000) decreased from 151 to 117 (2005-2020). The maximum inter-area ADI gap decreased modestly (34.64 to 32.50). Although the correlation between ADI and HCV prevalence was weak across all areas, it was markedly stronger in high-prevalence areas (≥200/100 000). In logistic regression, residents of the most deprived areas had elevated risks vs the least deprived (2020 adjusted OR 1.37). Multilevel models showed age (individual level) and area HCV prevalence (area level) were dominant determinants. Deprivation increased an individual's odds of HCV case status in ADI-only models; however, this association was not statistically significant after adjusting for area-level HCV prevalence and individual factors. Conclusions: Effective HCV elimination requires tailored screening and treatment strategies that prioritise socioeconomically vulnerable areas among the high-prevalence areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.